Aristo Bio-Tech Share Price Update: Key Metrics and Investment Insights
Aristo Bio-Tech and Lifescience Ltd., a prominent player in India's agrochemical sector, has been garnering attention from investors and analysts alike. As of September 6, 2025, the company's stock is trading at ₹122.30 on the National Stock Exchange (NSE). This article delves into the latest financial metrics, recent performance, and investment considerations for Aristo Bio-Tech.
Company Overview
Incorporated on March 17, 2005, Aristo Bio-Tech and Lifescience Ltd. specializes in the manufacturing, formulation, and distribution of agrochemical products, including insecticides, herbicides, fungicides, and plant growth regulators. The company has expanded its operations beyond its home state, establishing a presence in Punjab and Uttar Pradesh. Additionally, Aristo Bio-Tech offers contract manufacturing, job work, and toll manufacturing services for crop protection companies.
Stock Performance
-
Current Share Price: ₹122.30
-
52-Week High: ₹164.00
-
52-Week Low: ₹84.55
-
Market Capitalization: ₹83.26 Crore
-
Price-to-Earnings (P/E) Ratio: 20.49
-
Price-to-Book (P/B) Ratio: 2.23
-
Earnings Per Share (EPS): ₹5.97
-
Dividend Yield: 0.41%
-
Return on Equity (ROE): 11.3%
-
Return on Capital Employed (ROCE): 12.4%
-
Face Value: ₹10.00
These metrics indicate a company with steady profitability and moderate valuation multiples, making it an attractive option for value-focused investors.
Recent Financial Highlights
In the fiscal year ending March 31, 2025, Aristo Bio-Tech reported a revenue of ₹318 Crore, with a net profit of ₹4.06 Crore. The company's operating profit margin stood at 4%, reflecting efficient cost management. Over the past three years, the company has achieved a compounded annual growth rate (CAGR) of 24% in sales and 41% in profits, underscoring its robust growth trajectory.
Dividend History
Aristo Bio-Tech has demonstrated a commitment to rewarding shareholders. On September 1, 2025, the company declared a dividend of ₹0.50 per share, reflecting its stable cash flow and shareholder-friendly policies.
Technical Analysis
From a technical standpoint, Aristo Bio-Tech's stock has shown resilience. The 52-week high of ₹164.00 and the current price of ₹122.30 suggest potential for price appreciation. However, investors should monitor market conditions and company-specific developments that could impact stock performance.
Upcoming Events
-
Annual General Meeting (AGM): Scheduled for September 8, 2025, the AGM will provide shareholders with insights into the company's strategic direction and future plans.
Investment Considerations
Investors considering Aristo Bio-Tech should weigh the following factors:
-
Industry Position: As a key player in the agrochemical sector, the company's products are essential for agricultural productivity, positioning it favorably within the industry.
-
Financial Stability: With consistent revenue growth and profitability, Aristo Bio-Tech exhibits financial stability, reducing investment risk.
-
Dividend Policy: The company's regular dividend payouts are indicative of its strong cash flow and commitment to shareholder returns.
-
Market Volatility: Like all stocks, Aristo Bio-Tech is subject to market fluctuations. Investors should assess their risk tolerance before investing.
Conclusion
Aristo Bio-Tech and Lifescience Ltd. presents a compelling case for investors seeking exposure to the agrochemical sector. With strong financials, a consistent dividend history, and a strategic market position, the company offers potential for long-term growth. However, prospective investors should conduct thorough research and consider market dynamics before making investment decisions.
